Eye Cancers Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma
Conditions:   Melanoma (Skin);   Melanoma, Uveal Intervention:   Drug: Tebentafusp Sponsors:   University of Oxford;   Immunocore Ltd;   Natera, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials

Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Na ïve Metastatic Uveal Melanoma
Condition:   Melanoma, Uveal Interventions:   Drug: Pembrolizumab;   Drug: Lenvatinib Sponsors:   Providence Health & Services;   Merck Sharp & Dohme Corp.;   Eisai Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2022 Category: Research Source Type: clinical trials